<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04795622</url>
  </required_header>
  <id_info>
    <org_study_id>M960101056</org_study_id>
    <nct_id>NCT04795622</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum</brief_title>
  <official_title>Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merz North America, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ulthera, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Merz North America, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Demonstrate superiority of treatment with the Ulthera DeepSEE System compared to&#xD;
           untreated control for the improvement of skin laxity of the lower face and submental&#xD;
           area.&#xD;
&#xD;
        2. Demonstrate the safety of treatment with the Ulthera DeepSEE System for the improvement&#xD;
           of skin laxity of the lower face and submental area.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 16, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of subjects with improvement in lower face and submental skin laxity at Day 90 comparing Day 90 photographs with baseline photographs</measure>
    <time_frame>From baseline to day 90</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Displacement of skin (mm) in the submentum at Day 90 compared to baseline</measure>
    <time_frame>From baseline to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with any improvement on the Investigator Global Aesthetic Improvement Scale (iGAIS) at Day 90 compared to baseline photographs</measure>
    <time_frame>From baseline to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with any improvement on the Subject Global Aesthetic Improvement Scale (sGAIS) at Day 90 compared to baseline photographs</measure>
    <time_frame>From baseline to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in FACE-Q™ Satisfaction with Lower Face and Jawline score (Rasch-transformed) at Day 90</measure>
    <time_frame>From baseline to day 90</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">201</enrollment>
  <condition>Improvement in Skin Laxity of the Lower Face and Submentum</condition>
  <arm_group>
    <arm_group_label>Treatment Ulthera System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed-treatment Ulthera System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultherapy treatment</intervention_name>
    <description>Focused ultrasound energy delivered below the surface of the skin</description>
    <arm_group_label>Treatment Ulthera System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Untreated-control / delayed-treatment</intervention_name>
    <description>Untreated-control, followed by Ultherapy treatment (focused ultrasound energy delivered below the surface of the skin)</description>
    <arm_group_label>Delayed-treatment Ulthera System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Mild to moderate lower face and/or submental laxity that is amenable to improvement with&#xD;
        non-invasive intervention and is not severe enough for surgical intervention;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Scarring in area(s) to be treated;&#xD;
&#xD;
          -  Any active implants (e.g., pacemakers or defibrillators) in the area(s) to be treated;&#xD;
&#xD;
          -  Any metallic implants in area(s) to be treated;&#xD;
&#xD;
          -  Any open wounds or lesions in the area(s) to be treated;&#xD;
&#xD;
          -  Body mass index (BMI) less than 19 or greater than 30; or&#xD;
&#xD;
          -  Gain or loss of ≥ 2 BMI units within the previous 90 days or has the intention to gain&#xD;
             or lose ≥ 2 BMI units during the course of the trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merz Medical Expert</last_name>
    <role>Study Director</role>
    <affiliation>Merz North America, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University First Hospital, Merz Investigational Site #0860003</name>
      <address>
        <city>Beijing</city>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Air Force General Hospital, Merz Investigational Site #0860002</name>
      <address>
        <city>Beijing</city>
        <zip>100142</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital, Plastic Surgery, Merz Investigational Site #0860029</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai 9th Hospital, Plastic Surgery, Merz Investigational Site #0860015</name>
      <address>
        <city>Shanghai</city>
        <zip>200011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital Shanghai, Merz Investigational Site #0860004</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 9, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cutis Laxa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

